Prasugrel or Ticagrelor for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Does it Matter?

被引：1
|
作者：
Giri, Jay [1 ]
Nathan, Ashwin [1 ]
机构：
[1] Univ Penn, Cardiovasc Outcomes Qual & Evaluat Res Ctr, Leonard Davis Inst Hlth Econ, Cardiovasc Med Div, Philadelphia, PA 19104 USA
来源：
JACC-CARDIOVASCULAR INTERVENTIONS | 2018年 / 11卷 / 16期
关键词：
ACS; antiplatelet therapy; PCI; CLOPIDOGREL; INHIBITION;
D O I：
10.1016/j.jcin.2018.04.047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1587 / 1589
页数：3
相关论文
共 50 条
  • [21] Comparative effectiveness and safety of prasugrel versus ticagrelor in patients with acute coronary syndrome undergoing percutaneous transluminal coronary angioplasty
    Ray, Avik
    Najmi, Ahmad
    Khandelwal, Gaurav
    Jhaj, Ratinder
    Sadasivam, Balakrishnan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 177 - 177
  • [22] Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention
    Abraham, Neena S.
    Yang, Eric H.
    Noseworthy, Peter A.
    Inselman, Jonathan
    Yao, Xiaoxi
    Herrin, Jeph
    Sangaralingham, Lindsey R.
    Ngufor, Che
    Shah, Nilay D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (04) : 646 - 654
  • [23] Ticagrelor monotherapy vs clopidogrel monotherapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Feng, W.
    Chen, P. W.
    Ho, M. Y.
    Su, C. H.
    Huang, S. W.
    Cheng, C. W.
    Yeh, H., I
    Chen, C. P.
    Huang, W. C.
    Fang, C. C.
    Lin, H. W.
    Lin, S. H.
    Hsieh, I. C.
    Li, Y. H.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1722 - 1722
  • [24] Ticagrelor vs. clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention
    Jiyanboyevich, Yuldashev Soatboy
    Aslam, Imran
    Sadriddinovna, Burkhanova Dilovar
    INTERNATIONAL JOURNAL OF EARLY CHILDHOOD SPECIAL EDUCATION, 2022, 14 (03) : 10046 - 10052
  • [25] Prasugrel as Antiplatelet Therapy in Patients With Acute Coronary Syndromes or Undergoing Percutaneous Coronary Intervention
    Fletcher, Barbara
    Thalinger, Karen K.
    CRITICAL CARE NURSE, 2010, 30 (05) : 45 - 54
  • [26] Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention Reply
    You, Seng Chan
    Gupta, Aakriti
    Krumholz, Harlan M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (09): : 890 - 891
  • [27] Comparison of prasugrel and ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized and non-randomized studies
    Watti, Hussam
    Dahal, Khagendra
    Zabher, Henock G.
    Katikaneni, Pavan
    Modi, Kalgi
    Abdulbaki, Abdulrahman
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 249 : 66 - 72
  • [28] Effectiveness and safety of reduced dose prasugrel versus standard dose ticagrelor in East Asian patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Huang, Hsin-Yi
    Wang, Chi-Chuan
    Wu, Yee-Jen
    Wu, Chien-Chih
    Huang, Ling-Ya
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 12 - 12
  • [29] Cost-effectiveness of prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention
    Spartalis, Michael
    Tzatzaki, Eleni
    Nikiteas, Nikolaos I.
    Spartalis, Eleftherios
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 251 : 32 - 32
  • [30] Impact of the Adjusted Dosing Regimen of Prasugrel for Japanese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Takahashi, Jun
    CIRCULATION JOURNAL, 2014, 78 (07) : 1577 - 1578
12345